NSHRF yields 8000.00% · JNJ yields 2.13%● Live data
📍 NSHRF pulled ahead of the other in Year 1
Combined, NSHRF + JNJ cover 0 of 12 months — good coverage
Which stock is actually better after tax? Adjust your rate to find out.
What's the optimal mix of NSHRF + JNJ for your $10,000?
Northern Shield Resources Inc., a natural resource company, engages in identifying, acquiring, and exploring mineral properties primarily in Eastern Canada. The company primarily explores for nickel, copper, gold, silver, and platinum group elements. It principally holds 88.5% interests in the Shot Rock property with 750 claims covering an area of 121 square kilometers located in Nova Scotia; 100% interests in the Huckleberry property comprising 72 claims with an area of 54 square kilometers located in north of Schefferville, Quebec; and 100% interests in the Idefix property with 40 claims covering an area of 18 square kilometers located in Labrador Trough, Québec. The company also holds an option agreement to acquire a 100% interest in the Merasheen property with 217 claims covering an area of 54 square kilometers located at the southern end of Merasheen Island in Placentia Bay, Newfoundland. Northern Shield Resources Inc. was founded in 1999 and is headquartered in Ottawa, Canada.
Full NSHRF Calculator →Johnson & Johnson, together with its subsidiaries, researches and develops, manufactures, and sells various products in the healthcare field worldwide, but strategically separated its Consumer Health business into Kenvue Inc. in 2023 to focus on its higher-growth, innovation-driven segments; the former Consumer Health brands (including TYLENOL, LISTERINE, and BAND-AID) are now owned by Kenvue. The company's core focus is now split between its Innovative Medicine (formerly Pharmaceutical) segment, which offers prescription products for complex diseases such as rheumatoid arthritis, various cancers, HIV/AIDS, and neurodegenerative disorders; and its MedTech (Medical Devices) segment, which provides advanced technology solutions including electrophysiology products, neurovascular care products, orthopaedics (hips, knees, spine), advanced surgery solutions, and disposable contact lenses under the ACUVUE brand. Company's two remaining segments primarily serve hospitals, healthcare professionals, wholesalers, and retailers, continuing its mission of advancing human health since its founding in 1886 and its current basing in New Brunswick, New Jersey.
Full JNJ Calculator →Save your analysis + weekly dividend insights. Free forever.
⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.